Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

(2018) M Ignatiadis et al.   ANNALS OF ONCOLOGY

Quantified postsurgical small cell size CTCs and EpCAM + circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse

(2018) Liang Wang et al.   CANCER LETTERS

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

(2018) François-Clément Bidard et al.   JNCI-Journal of the National Cancer Institute

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

(2018) François-Clément Bidard et al.   JNCI-Journal of the National Cancer Institute

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients

(2018) Camille Emprou et al.   Cancer Medicine

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer

(2018) Maria A Papadaki et al.   MOLECULAR CANCER THERAPEUTICS

Evidence for circulating cancer stem-like cells and epithelial–mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy

(2017) Sheefa Mirza et al.   TUMOR BIOLOGY

Molecular characterization of breast cancer CTCs associated with brain metastasis

(2017) Debasish Boral et al.   Nature Communications

Gene expression profiling and DNA methylation analyses of CTCs

(2016) Evi S. Lianidou   Molecular Oncology

Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients

(2016) Y Ning et al.   PHARMACOGENOMICS JOURNAL

Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment

(2016) Maren Bredemeier et al.   Oncotarget

Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer

(2016) Sebastian Schölch et al.   Oncotarget

Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation

(2016) Ioannis Voutsadakis   Journal of Clinical Medicine

Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer

(2014) Maria A Papadaki et al.   BMC CANCER

Current Approaches and Challenges in Early Detection of Breast Cancer Recurrence

(2014) Erika J. Schneble et al.   Journal of Cancer

Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

(2014) Suling Liu et al.   Stem Cell Reports

Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens on the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer

(2013) N Xenidis et al.   BRITISH JOURNAL OF CANCER

Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer

(2013) Yoomi Choi et al.   HUMAN PATHOLOGY

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

(2013) Irène Baccelli et al.   NATURE BIOTECHNOLOGY

The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis

(2013) L. Zhang et al.   Science Translational Medicine

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

(2012) V. Georgoulias et al.   ANNALS OF ONCOLOGY

Circulating tumour cells in non-metastatic breast cancer: a prospective study

(2012) Anthony Lucci et al.   LANCET ONCOLOGY

Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

(2012) A. Giordano et al.   MOLECULAR CANCER THERAPEUTICS

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

(2012) Michal Mego et al.   Journal of Cancer

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR

(2011) Areti Strati et al.   BMC CANCER

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

(2011) Bahriye Aktas et al.   GYNECOLOGIC ONCOLOGY

Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α

(2011) F Vesuna et al.   ONCOGENE

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

(2009) Panayiotis A. Theodoropoulos et al.   CANCER LETTERS

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

(2009) Nikolaos Xenidis et al.   JOURNAL OF CLINICAL ONCOLOGY

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH